Charles Brandes acquired 6.71 Million Pfizer shares worth $154 Million. That's 1.77% of their equity portfolio (15th largest holding). The first Pfizer trade was made in Q1 2013. Since then Charles Brandes bought shares nineteen more times and sold shares on 28 occasions. The investor's estimated purchase price is $200 Million, resulting in a loss of 23%.